Research & Treatment News
First FDA-cleared Alzheimer's blood test could make diagnoses faster, more accurate
A new blood test that detects a hallmark of Alzheimer's is poised to change the way doctors diagnose and treat the disease.
The test, the first of its kind to be cleared by the Food and Drug Administration, is for people 55 and older who already have memory problems or other signs and symptoms of Alzheimer's.
Scientists discover potential new targets for Alzheimer’s drugs
By combining information from many large datasets, MIT and Harvard Medical School researchers have identified several new potential targets for treating or preventing Alzheimer’s disease.
The study revealed genes and cellular pathways that haven’t been linked to Alzheimer’s before, including one involved in DNA repair. Identifying new drug targets is critical because many of the Alzheimer’s drugs that have been developed to this point haven’t been as successful as hoped.
